kaspmedПрикаспийский вестник медицины и фармацииTitle2712-8164ФГБОУ ВО Астраханский ГМУ Минздрава России10.17021/2712-8164-2024-4-53-59kaspmed-44Research ArticleСтатьиОсобенности клиники и комплексного лечения вторичной гнойной раны у больного после тяжелой коронавирусной инфекции (COVID-19)Features of the clinical picture and comprehensive treatment of second purulent wound in patients after severe coronavirus infection (COVID-19)ТопчиевМ. А.TopchievM. A.

Михаил Андреевич Топчиев, доктор медицинских наук, профессор, заведующий кафедрой общей хирургии с курсом последипломного образования

Астрахань

Mikhail A. Topchiev, Dr. Sci. (Med.), Professor, Head of the Department

Astrakhan

topchievma@mail.ruМельниковВ. В.Mel’nikovV. V.

Владимир Витальевич Мельников, доктор медицинских наук, доцент, доцент кафедры общей хирургии с курсом последипломного образования

Астрахань

Vladimir V. Мel’nikov, Dr. Sci. (Med.), Associate Professor, Associate Professor of the Department

Astrakhan

mvvastr@mail.ruПаршинД. С.ParshinD. S.

Дмитрий Сергеевич Паршин, доктор медицинских наук, доцент, доцент кафедры общей хирургии с курсом последипломного образования

Астрахань

Dmitriy S. Parshin, Dr. Sci. (Med.), Associate Professor, Associate Professor of the Department

Astrakhan

parshin.doc@gmail.ruГололобовА. М.GololobovA. M.

Александр Михайлович Гололобов, врач-хирург

Астрахань

Aleksandr M. Gololobov, surgeon

Astrakhan

dok-250@mail.ruАдямовТ. Д.AbyamovT. D.

Талгат Даутович Адямов, врач-хирург

Астрахань

Talgat D. Adyamov, surgeon

Astrakhan

adyamova1963@mail.ruЧотчаевМ. К.ChotchaevM. K.

Марат Казбекович Чотчаев, кандидат медицинских наук, доцент кафедры общей хирургии

Ставрополь

Marat K. Chotchaev, Cand. Sci. (Med.), Associate Professor of the Department

Stavropol

chotcha.mk@gmail.comАстраханский государственный медицинский университетРоссияAstrakhan State Medical UniversityRussian FederationАстраханский государственный медицинский университет; Городская клиническая больница № 3 имени С. М. КироваРоссияAstrakhan State Medical University; S. M. Kirov City Clinical Hospital No. 3Russian FederationГородская клиническая больница № 3 имени С. М. КироваРоссияS. M. Kirov City Clinical Hospital No. 3Russian FederationСтавропольский государственный медицинский университетРоссияStavropol State Medical UniversityRussian Federation2024130320255453–59Copyright © Топчиев М.А., Мельников В.В., Паршин Д.С., Гололобов А.М., Адямов Т.Д., Чотчаев М.К., 20252025Топчиев М.А., Мельников В.В., Паршин Д.С., Гололобов А.М., Адямов Т.Д., Чотчаев М.К.Topchiev M.A., Mel’nikov V.V., Parshin D.S., Gololobov A.M., Abyamov T.D., Chotchaev M.K.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.kaspmed.ru/jour/article/view/44

Представлено клиническое наблюдение пациента с наличием сахарного диабета второго типа после проведения реконструктивной ангиопластики бедренной артерии справа, c развитием острого тромбоза шунта, влажной гангрены и ампутации в период новой коронавирусной инфекции COVID-19. Применение оксигенированных препаратов ликвидирует дефицит оксигенации тканей, а местное лечение раны с применением аппаратной гидрохирургической обработки и потоков экзогенного оксида азота благотворно влияет на обменные процессы заживления раны, позволяет подавить активность раневой микробиоты и предотвратить летальный исход.

The article considers a clinical observation of a patient with type 2 diabetes mellitus after reconstructive angioplasty of the femoral artery on the right, the development of acute bypass thrombosis, wet gangrene and amputation during the new coronavirus infection COVID-19. The use of oxygenated drugs eliminates tissue oxygenation deficiency, and local wound treatment using hardware hydrosurgical treatment and exogenous nitric oxide flows has a beneficial effect on metabolic processes of wound healing, allows suppressing the activity of wound microbiota and preventing death.

вторичная гнойная ранасахарный диабетэкзогенный оксид азотановая коронавирусная инфекция COVID-19second purulentdiabetes mellitusexogenous nitric oxideCOVID-19ReferencesDuloquin G., Pommier T., Georges M., Giroud M., Guenancia C., Béjot Y., Laurent G., Rabec C. Is COVID 19 Infection a Multiorganic Disease? Focus on Extrapulmonary Involvement of SARS-CoV-2 // Journal of Clinical Medicine. 2024. Vol. 13, no. 5. P. 1397. doi: 10.3390/jcm13051397.Duloquin G., Pommier T., Georges M., Giroud M., Guenancia C., Béjot Y., Laurent G., Rabec C. Is COVID 19 Infection a Multiorganic Disease? Focus on Extrapulmonary Involvement of SARS-CoV-2. Journal of Clinical Medicine. 2024: 13 (5): 1397. doi: 10.3390/jcm13051397.Boulos M., Bassal T., Layyous A., Basheer M., Assy N. Inflammation in COVID-19: A Risk for Superinfections // COVID. 2022. Vol. 2, no. 11. P. 1609–1624. doi:10.3390/covid2110116.Boulos M., Bassal T., Layyous A., Basheer M., Assy N. Inflammation in COVID-19: A Risk for Superinfections. COVID. 2022; 2 (11): 1609–1624. doi:10.3390/covid2110116.Blanco-Melo D., Nillson-Paynt B. E., Liu W. C. Imbalanced host response to SARS-CoV-2 drives development of COVID-19 // Cell. 2020. Vol. 181, no. 5. P. 1036–1045. doi: 10.16/j.cell.2020.02.026.Blanco-Melo D., Nillson-Paynt B. E., Liu W. C. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell. 2020; 181 (5): 1036–1045. doi: 10.16/j.cell.2020.02.026.Batiha G. E., Al-Kuraishy H. M., Al-Gareeb A. I., Welson N. N. Pathophysiology of Post-COVID syndromes: a new perspective // Virology Journal. 2022. Vol. 19, no. 1. P. 158. doi: 10.1186/s12985-022-01891-2.Batiha G. E., Al-Kuraishy H. M., Al-Gareeb A. I., Welson N. N. Pathophysiology of Post-COVID syndromes: a new perspective. Virology Journal. 2022; 19 (1): 158. doi: 10.1186/s12985-022-01891-2.Tomasiewicz K., Woroń J., Kobayashi A. Krasinski Z., Rydzewska G., Szymanski F. M. Post-COVID-19 syndrome in everyday clinical practice: interdisciplinary expert position statement endorsed by the Polish Society of Civilization Diseases // Polish Archives of Internal Medicine. 2024. Vol. 134. P. 16728. doi: 10.20452/pamw.16728.Tomasiewicz K., Woroń J., Kobayashi A. Krasinski Z., Rydzewska G., Szymanski F. M. Post-COVID-19 syndrome in everyday clinical practice: interdisciplinary expert position statement endorsed by the Polish Society of Civilization Diseases. Polish Archives of Internal Medicine. 2024. Vol. 134. P. 16728. doi: 10.20452/pamw.16728.Facciponte D. N., Shaw P. Venous gangrene associated with COVID-19: Successful limb preservation strategies with optimal wound management // Annals of Vascular Surgery – Brief Reports and Innovations. 2022. Vol. 2, no. 2. P. 100095. doi: 10.1016/j.avsurg.2022.100095.Facciponte D. N., Shaw P. Venous gangrene associated with COVID-19: Successful limb preservation strategies with optimal wound management. Annals of Vascular Surgery – Brief Reports and Innovations. 2022. Vol. 2, no. 2. P. 100095. doi: 10.1016/j.avsurg.2022.100095.Patil B. U., Hivre M. G., Pravinkumar V., Gupta A., Gupta D. COVID-19 Associated Peripheral Gangrene: A Case Series. Mustansiriya Medical Journal. 2023. Vol. 22, no. 2. P. 224–228. doi: 10.4103/mj. mj_39_23.Patil B. U., Hivre M. G., Pravinkumar V., Gupta A., Gupta D. COVID-19 Associated Peripheral Gangrene: A Case Series. Mustansiriya Medical Journal. 2023. Vol. 22, no. 2. P. 224–228. doi: 10.4103/mj.mj_39_23.Raj S. T., Bruce A. W., Anbalagan M., Srinivasan H., Chinnappan S., Rajagopal M., Khanna K., Chandramoorthy H. C., Mani R. R. COVID-19 influenced gut dysbiosis, postacute sequelae, immune regulation, and therapeutic regimens. Frontiers in Cellular and Infection Microbiology. 2024. Vol. 14. P. 1384939. doi: 10.3389/fcimb.2024.1384939.Raj S. T., Bruce A. W., Anbalagan M., Srinivasan H., Chinnappan S., Rajagopal M., Khanna K., Chandramoorthy H. C., Mani R. R. COVID-19 influenced gut dysbiosis, postacute sequelae, immune regulation, and therapeutic regimens. Frontiers in Cellular and Infection Microbiology. 2024. Vol. 14. P. 1384939. doi: 10.3389/fcimb.2024.1384939.Leggiadro R. J. Bacterial Coinfections in Lung Tissue Specimens from Fatal Cases of 2009 Pandemic Influenza A (H1N1) – United States, May – August 2009. The Pediatric Infectious Disease Journal. 2010. Vol. 29, no. 1. P. 22, January 2010. doi: 10.1097/01.inf.0000366838.82857.78.Leggiadro R. J. Bacterial Coinfections in Lung Tissue Specimens from Fatal Cases of 2009 Pandemic Influenza A (H1N1) – United States, May – August 2009. The Pediatric Infectious Disease Journal. 2010. Vol. 29, no. 1. P. 22, January 2010. doi: 10.1097/01.inf.0000366838.82857.78.The ANZIC Influenza Investigators. Critical care services and the H1N1 (2009) influenza epidemic in Australia and New Zealand in 2010: the impact of the second winter epidemic. Critical Care. 2011. Vol. 15. P. R143. doi: 10.1186/cc10266.The ANZIC Influenza Investigators. Critical care services and the H1N1 (2009) influenza epidemic in Australia and New Zealand in 2010: the impact of the second winter epidemic. Critical Care. 2011. Vol. 15. P. R143. doi: 10.1186/cc10266. 11. Ruiyun Li et al. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2). Science. 2020. Vol. 368. P. 489–493. doi: 10.1126/science.abb3221.Ruiyun Li et al. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2). Science. 2020. Vol. 368. P. 489–493. doi: 10.1126/science.abb3221.Musuuza J. S., Watson L., Parmasad V., Putman-Buehler N., Christensen L., Safdar N. Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: A systematic review and meta analysis. PLoS One. 2021. Vol. 16, no. 5. P. e0251170. doi: 10.1371/journal.pone.0251170.Musuuza J. S., Watson L., Parmasad V., Putman-Buehler N., Christensen L., Safdar N. Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: A systematic review and meta analysis. PLoS One. 2021. Vol. 16, no. 5. P. e0251170. doi: 10.1371/journal.pone.0251170.Musuuza J. S., Watson L., Parmasad V., Putman-Buehler N., Christensen L., Safdar N. Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: A systematic review and meta analysis. PLoS One. 2021. Vol. 16, no. 5. P. e0251170. doi: 10.1371/journal.pone.0251170.

The authors declare that there are no conflicts of interest present.